ETV6/RUNX1 fusion at diagnosis and relapse: Some prognostic indications

Genes Chromosomes and Cancer

Volumn 43, Issue 1, 2005, Pages 54-71

  Martineau, Mary ^a,f   Jalali, G Reza ^a,e   Barber, Kerry E ^a   Broadfield, Zoë J ^a   Cheung, Kan Luk ^a   Lilleyman, John ^b   Moorman, Anthony V ^a   Richards, Sue ^c   Robinson, Hazel M ^a   Ross, Fiona ^d   Harrison, Christine J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RELAPSE; CHILD; CHROMOSOME 12; CHROMOSOME 21; CLINICAL ARTICLE; CLINICAL FEATURE; CLONE; CONTROLLED STUDY; CYTOGENETICS; ETV6 GENE; FEMALE; FUSION GENE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; INTERPHASE; MALE; METAPHASE; PARTIAL TRISOMY 10; PRIORITY JOURNAL; PROGNOSIS; RUNX1 GENE; X CHROMOSOME;

ADOLESCENT; ADULT; ARTIFICIAL GENE FUSION; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECURRENCE; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 20144387358     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20158     Document Type: Article

References (60)

1. Ameye G, Jacquy C, Zenebergh A, Stul M, Vaerman JL, Bilhou-Nabera C, Libouton JM, Deneys V, Martiat P, Hagemeijer A, Cornu G, Verellen-Dumoulin C, Michaux L. 2000. The value of interphase fluorescence in situ hybridization for the detection of translocation t(12;21) in childhood acute lymphoblastic leukemia. Ann Hematol 79:259-268.
2. Andreasson P, Höglund M, Bekassy AN, Garwicz S, Heldrup J, Mitelman F, Johansson B. 2000. Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias. Eur J Haematol 65:40-51.
3. Breivik J, Gaudernack G. 1999. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 9:245-254.
4. Broadfield ZJ, Hain RD, Harrison CJ, Reza JG, McKinley M, Michalova K, Robinson HM, Zemanova Z, Martineau M. 2004. Complex chromosomal abnormalities in utero, 5 years before leukaemia. Br J Haematol 126:307-312.
5. Bumm T, Muller C, Al Ali HK, Krohn K, Shepherd P, Schmidt E, Leiblein S, Franke C, Hennig E, Friedrich T, Krahl R, Niederwieser D, Deininger MW. 2003. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood 101:1941-1949.
6. Calabrese G, Stuppia L, Franchi PG, Peila R, Morizio E, Liberati AM, Spadano A, Di Lorenzo R, Donti E, Antonucci A. 1994. Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet 78:153-159.
7. Chow CD, Dalla-Pozza L, Gottlieb DJ, Hertzberg MS. 1999. Two cases of very late relapsing ALL carrying the TEL:AML1 fusion gene. Leukemia 13:1893-1894.
8. Douet-Guilbert N, Morel F, Le Bris MJ, Herry A, Le Calvez G, Marion V, Berthou C, De Braekeleer M. 2003. Translocation (12;21) followed by insertion of chromosome 3 material in the derivative chromosome 12 in a case of childhood acute Symphoblastic leukemia. Cancer Genet Cytogenet 142:120-123.
9. Elghezal H, Le Guyader G, Radford-Weiss I, Perot C, van den AJ, Eydoux P, Vekemans M, Romana SP. 2001. Reassessment of childhood B-lineage lymphoblastic leukemia karyotypes using spectral analysis. Genes Chromosomes Cancer 30:383-392.
10. Fears S, Vignon C, Bohlander SK, Smith S, Rowley JD, Nucifora G. 1996. Correlation between the ETV6/CBFA2 (TEL/AML1) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 17:127-135.
11. Fitzgerald PH, Morris CM. 1991. Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement? Cancer Genet Cytogenet 57:143-151.
12. Ford AM, Fasching K, Panzer-Grumayer ER, Koenig M, Haas OA, Greaves MF. 2001. Origins of "late" relapse in childhood acute Iymphoblastic leukemia with TEL-AML1 fusion genes. Blood 98:558-564.
13. Hann I, Vora A. Harrison G, Harrison C, Martineau M, Moorman AV, Secker Walker LM, Eden O, Hill F, Gibson B, Richards S. 2001. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 113:103-114.
14. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. 1997. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 90:4933-4937.
15. Harrison CJ, Martineau M, Seeker-Walker LM. 2001. The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol 113:3-10.
16. Hishida A, Yamamoto K, Matsushita T, Tanimoto M, Saito H, Emi N. 2003. Trisomy X in Philadelphia chromosome-negative cells during the course of Philadelphia chromosome-positive chronic myelocytic leukemia. Cancer Genet Cytogenet 142:83-85.
17. Hubner S, Cazzaniga G, Flohr T, van dV, V, Konrad M, Potschger U, Basso G, Schrappe M, van Dongen JJ, Bartram CR, Biondi A, Panzer-Grumayer ER. 2004. High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias. Leukemia 18:84-91.
18. Huntly BJ, Bench A, Green AR. 2003. Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 102:1160-1168.
19. ISCN. 1995. An International System for Human Cytogenetic Nomenclature. Mitelman F. editor. Basel, Switzerland: S. Karger.
20. Jabbar Al-Obaidi MS, Martineau M. Bennett CF, Franklin IM, Goldstone AH, Harewood L, Jalali GR, Prentice HG, Richards SM, Roberts K, Harrison CJ. 2002. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 16:669-674.
21. Jalali GR, Barber KE, Broadfield ZJ, Cheung KL, Harris RL, Harrison CJ, Moorman AV, Robinson HM, Martineau M. 2003a. Duplication or translocation? The origin of a second der(12). Blood 102:867a.
22. Jalali GR, Martineau M, Ford AM, Greaves M, Stevens RF, Harrison CJ. 2003b. A unique variant of ETV6/AML1 fusion in a child with acute lymphoblastic leukemia. Leukemia 17:993-995.
23. Jamil A, Theil KS, Kahwash S, Ruymann FB, Klopfenstein KJ. 2000. TEL/AML-1 fusion gene: its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 122:73-78.
24. Jarosova M, Holzerova M, Mihal V, Blatny J, Lakoma I, Trka J, Pikalova Z, Hrusak O, Indrak K. 2002. Additional evidence of genetic changes in children with ALL and TEL/AML1 fusion gene. Leukemia 16:1873-1875.
25. Jarosova M, Holzerova M, Mihal V, Lakoma I, Divoky V, Blazek B, Pospisilova D, Hajduch M, Novak Z, Dusek L, Koptikova J, Poulsen TS, Indrak K. 2003. Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases. Cancer Genet Cytogenet 145:161-168.
26. Kempski H, Chalker J, Chessells JM, Sturt N, Brickell P, Webb J, MacDonald Crink J, Reeves B. 1999. An investigation of the t(12;21) rearrangement in children with B-precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods. Br J Haematol 105:684-689.
27. Kempski H, Mensa-Bonsu KA, Kearney L, JalaSi GR, Hann I, Kurshid M, Greaves M. 2003. Prenatal chromosomal diversification of leukemia in monozygotic twins. Genes Chromosomes Cancer 37:406-411.
28. Konrad M, Metzler M, Panzer S, Ostreicher I, Peham M, Repp R, Haas OA, Gadner H, Panzer-Grumayer ER. 2003. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood 101:3635-3640.
29. Loh ML, Rubnitz JE. 2002. TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curr Opin Hematol 9:345-352.
30. Loncarevic IF, Roitzheim B, Ritterbach J, Viehmann S, Borkhardt A, Lampert F, Harbott J. 1999. Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/ AML1 gene fusion. Genes Chromosomes Cancer 24:272-277.
31. Lu XY, Harris CP, Cooley L, Margolin J, Steuber PC, Sheldon M, Rao PH, Lau CC. 2002. The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia. Leukemia 16:2222-2227:
32. Ma SK, Wan TS, Cheuk AT, Fung LF, Chan GC, Chan SY, Ha SY, Chan LC. 2001. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study. Leukemia 15:1442-1447.
33. Manor E, Shubinsky G, Moser AM, Gurevitch D, Chatach F, Yermiahu T, Kapelushnik J. 2003. Conversion of childhood acute lymphocytic leukemia (L2) with a double t(12;21) to juvenile myelomonocytic leukemia with a novel t(4;11)(p12;q23): a cytogenetic, morphologic, and immunophenotypic study. Cancer Genet Cytogenet 147:110-114.
34. Martineau M, Clark R, Farrell DM, Hawkins JM, Moorman AV, Seeker-Walker LM. 1996. Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding. Genes Chromosomes Cancer 17:21-30.
35. Martineau M, Greaves M, Bennett CF, Butler TA, Jalali GR, Kasprzyk A, O'Connor H, Roberts K, Swanton S, Harrison CJ. 1998. Cytogenetic pointers to the t(12;21) translocation. Blood 92:392a.
36. Martineau M, Jalali GR, Bennett CF, Byatt S-A, Harewood L, Pinson M-P, Roberts K, Sumption N. 2000. Poor prognosis ETV6/AML1 fusion. FISH reveals some common features. Blood 96:711a.
37. Mathew S, Shurtleff SA, Raimondi SC. 2001. Novel cryptic, complex rearrangements involving ETV6-CBFA2 (TEL-AML1) genes identified by fluorescence in situ hybridization in pediatric patients with acute lymphoblastic leukemia. Genes Chromosomes Cancer 32:188-193.
38. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR. 1996. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood. 88:4252-4258.
39. Moorman AV, Martineau M, Harrison CJ. 2003a. Response to Cuneo et al. Leukemia 17:477.
40. Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR, Broadfield ZJ, Harris RL, Barber KE, Lilleyman J, Kinsey S, Eden O, Vora AJ, Mitchell CD, Harrison CJ. 2003b. Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK Medical Research Council (MRC) ALL97 trial. Blood 102:64a.
41. Nordgren A, Heyman M, Sahlen S, Schoumans J, Söderhäll S, Nordenskjöld M, Blennow E. 2002. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases. Eur J Haematol 68:31-41.
42. O'Dwyer ME, Gatter KM, Loriaux M, Druker BJ, Olson SB, Magenis RE, Lawce H, Mauro MJ, Maziarz RT, Braziel RM. 2003. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. Leukemia 17:481-487.
43. Odero MD, Carlson K, Calasanz MJ, Lahortiga I, Chinwalla V, Rowley JD. 2001. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 31:134-142.
44. Pine SR, Wiemels JL, Jayabose S, Sandoval C. 2003. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leuk Res 27:155-164.
45. Raynaud SD, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Maryen P, Grandchamp B. 1996. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891-2899.
46. Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S, Raimondi S. 1998. Cytogenetic aspects of the t(12;21). Blood 92: 392a.
47. Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S, Raimondi SC. 1999. Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;2D-positive acute lymphoblastic leukemia. Leukemia 13:1325-1330.
48. Reddy KS, Yang X, Mak L, Wang S, Johnston M. 2000. A child with ALL and ETV6/AML1 fusion on a chromosome 12 due to an insertion of AML1 und loss of ETV6 from the homolog involved in z t(12;15)(p13;q15). Genes Chromosomes Cancer 29:106-109.
49. Reid AG, Huntly BJ, Grace C, Green AR, Nacheva EP. 2003. Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. Br J Haematol 121:419-427.
50. Riesch M, Niggli FK, Leibundgut K, Caflisch U, Betts DR. 2001. Loss of X chromosome in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 125:27-29.
51. Romana SR Le Coniat M, Berger R. 1994. t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9:186-191.
52. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. 1995. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662-3670.
53. Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard OA, Berger R. 1996. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 10:167-170.
54. Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Buijs A, Grosveld G, Behm FG. 1997. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol 15:1150-1157.
55. Seeger K, Adams HP, Buchwald D, Beyermann B, Kremens B, Niemeyer C, Ritter J, Schwabe D, Harms D, Schrappe M, Henze G. 1998. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Munster Study Group. Blood 91:1716-1722.
56. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC-H, Pui C-H, Grosveld G, Downing JR. 1995. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985-1989.
57. Slater RM, Drunen Ev, Roitzheim B, Viehmann S, Beverloo HB, Harbott J. 1997. Variation in ETV6 and AML-1 in t(12;21) childhood ALL revealed by interphase FISH. Blood 90:222b-223b.
58. Stergianou K, Whitehouse M, Forman KM, Harewood L. 2001. A case of childhood ALL with two TEL/AML1 fusions in a hyperdiploid karyotype. J Med Genet 38:44.
59. Tsang KS, Li CK, Chik KW, Shing MM, Tsoi WC, Ng MH, Lau TT, Leung Y, Yuen PM. 2001. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol 68:91-98.
60. Weston VJ, McConville CM, Mann JR, Darbyshire PJ, Lawson S, Gordon J, Moss PA, Taylor AM, Stankovic T. 2001. Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukemia that can precede the t(12;21) translocation. Cancer Res 61:8547-8553.